000 | 01941 a2200541 4500 | ||
---|---|---|---|
005 | 20250514170319.0 | ||
264 | 0 | _c20040601 | |
008 | 200406s 0 0 eng d | ||
022 | _a0031-7012 | ||
024 | 7 |
_a10.1159/000074979 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Campos Grifoni, Samira | |
245 | 0 | 0 |
_aFunctional study of the [Ca2+]i signaling pathway in aortas of L-NAME-hypertensive rats. _h[electronic resource] |
260 |
_bPharmacology _cMar 2004 |
||
300 |
_a160-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a6-Ketoprostaglandin F1 alpha |
650 | 0 | 4 | _aAcetylcholine |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAorta, Thoracic _xdrug effects |
650 | 0 | 4 |
_aCaffeine _xpharmacology |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
650 | 0 | 4 |
_aHypertension _xchemically induced |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xadministration & dosage |
650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
650 | 0 | 4 |
_aNorepinephrine _xpharmacology |
650 | 0 | 4 |
_aPhenylephrine _xpharmacology |
650 | 0 | 4 |
_aPhorbol 12,13-Dibutyrate _xpharmacology |
650 | 0 | 4 |
_aPhorbol Esters _xmetabolism |
650 | 0 | 4 |
_aProstaglandins _xbiosynthesis |
650 | 0 | 4 |
_aProtein Kinase C _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTunica Intima _xdrug effects |
650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
700 | 1 | _aBendhack, Lusiane Maria | |
773 | 0 |
_tPharmacology _gvol. 70 _gno. 3 _gp. 160-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000074979 _zAvailable from publisher's website |
999 |
_c14476629 _d14476629 |